Allspice and Clove As Source of Triterpene Acids Activating the G Protein-Coupled Bile Acid Receptor TGR5

被引:23
|
作者
Ladurner, Angela [1 ]
Zehl, Martin [1 ,2 ,3 ]
Grienke, Ulrike [1 ]
Hofstadler, Christoph [1 ]
Faur, Nadina [1 ]
Pereira, Ftima C. [4 ]
Berry, David [4 ]
Dirsch, Verena M. [1 ]
Rollinger, Judith M. [1 ]
机构
[1] Univ Vienna, Fac Life Sci, Dept Pharmacognosy, Vienna, Austria
[2] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria
[3] Univ Vienna, Dept Analyt Chem, Vienna, Austria
[4] Univ Vienna, Dept Microbiol & Ecosyst Sci, Vienna, Austria
来源
基金
奥地利科学基金会;
关键词
TGR5; Syzygium aromaticum; Pimenta dioica; Kaempferia galanga; triterpene acids; OCCURRING PENTACYCLIC TRITERPENES; COROSOLIC ACID; MASLINIC ACID; GLYCOGEN-PHOSPHORYLASE; SYZYGIUM-AROMATICUM; OLEANOLIC ACID; GUT MICROBIOTA; PIMENTA-DIOICA; ADIPOSE-TISSUE; GPBAR1; TGR5;
D O I
10.3389/fphar.2017.00468
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Worldwide, metabolic diseases such as obesity and type 2 diabetes have reached epidemic proportions. A major regulator of metabolic processes that gained interest in recent years is the bile acid receptor TGR5 (Takeda G protein-coupled receptor 5). This G protein-coupled membrane receptor can be found predominantly in the intestine, where it is mainly responsible for the secretion of the incretins glucagon-like peptide 1 (GLP-1) and peptide YY (PYY). The aim of this study was (i) to identify plant extracts with TGR5-activating potential, (ii) to narrow down their activity to the responsible constituents, and (iii) to assess whether the intestinal microbiota produces transformed metabolites with a different activity profile. Chenodeoxycholic acid (CDCA) served as positive control for both, the applied cell-based luciferase reporter gene assay for TGR5 activity and the biotransformation assay using mouse fecal slurry. The suitability of the workflow was demonstrated by the biotransformation of CDCA to lithocholic acid resulting in a distinct increase in TGR5 activity. Based on a traditional Tibetan formula, 19 plant extracts were selected and investigated for TGR5 activation. Extracts from the commonly used spices Syzygium aromaticum (SaroE, clove), Pimenta dioica (PdioE, allspice), and Kaempferia galanga (KgalE, aromatic ginger) significantly increased TGR5 activity. After biotransformation, only KgalE showed significant differences in its metabolite profile, which, however, did not alter its TGR5 activity compared to non-transformed KgalE. UHPLC-HRMS (high-resolution mass spectrometry) analysis revealed triterpene acids (TTAs) as the main constituents of the extracts SaroE and PdioE. Identification and quantification of TTAs in these two extracts as well as comparison of their TGR5 activity with reconstituted TTA mixtures allowed the attribution of the TGR5 activity to TTAs. EC(50)s were determined for the main TTAs, i.e., oleanolic acid (2.2 +/- 1.6 mu M), ursolic acid (1.1 +/- 0.2 mu M), as well as for the hitherto unknown TGR5 activators corosolic acid (0.5 +/- 1.0 mu M) and maslinic acid (3.7 +/- 0.7 mu M). In conclusion, extracts of clove, allspice, and aromatic ginger activate TGR5, which might play a pivotal role in their therapeutic use for the treatment of metabolic diseases. Moreover, the TGR5 activation of SaroE and PdioE could be pinpointed solely to TTAs.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Cryo-EM structure of activated bile acids receptor TGR5 in complex with stimulatory G protein
    Geng Chen
    Xiankun Wang
    Yunjun Ge
    Ling Ma
    Qiang Chen
    Huihui Liu
    Yang Du
    Richard D. Ye
    Hongli Hu
    Ruobing Ren
    Signal Transduction and Targeted Therapy, 5
  • [22] The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells
    Keitel, Verena
    Reinehr, Roland
    Gatsios, Petros
    Rupprecht, Claudia
    Goerg, Boris
    Selbach, Oliver
    Haeussinger, Dieter
    Kubitz, Ralf
    HEPATOLOGY, 2007, 45 (03) : 695 - 704
  • [23] Cryo-EM structure of activated bile acids receptor TGR5 in complex with stimulatory G protein
    Chen, Geng
    Wang, Xiankun
    Ge, Yunjun
    Ma, Ling
    Chen, Qiang
    Liu, Huihui
    Du, Yang
    Ye, Richard D.
    Hu, Hongli
    Ren, Ruobing
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [24] Dual Activation of the Bile Acid Nuclear Receptor FXR and G-Protein-Coupled Receptor TGR5 Protects Mice against Atherosclerosis
    Miyazaki-Anzai, Shinobu
    Masuda, Masashi
    Levi, Moshe
    Keenan, Audrey L.
    Miyazaki, Makoto
    PLOS ONE, 2014, 9 (09):
  • [25] Bile Acid Receptor Activation Ameliorates Metabolic Disorders by Differentially Activating FXR or TGR5
    Jadhav, Kavita S.
    Xu, Yang
    Zhang, Yanqiao
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2017, 37
  • [26] Expression of bile acid receptor TGR5 in gastric adenocarcinoma
    Cao, Weibiao
    Tian, Wei
    Hong, Jie
    Li, Dan
    Tavares, Rosemarie
    Noble, Lelia
    Moss, Steven F.
    Resnick, Murray B.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2013, 304 (04): : G322 - G327
  • [27] SECONDARY BILE ACIDS PROTECT AGAINST INTESTINAL INFLAMMATION VIA BILE ACID TGR5 RECEPTOR
    Sinha, Sidhartha R.
    Haileselassie, Yeneneh
    Linh Nguyen
    Tropini, Carolina
    Becker, Laren S.
    Sim, Davis
    Bittinger, Kyle
    Sonnenburg, Justin
    Habtezion, Aida
    GASTROENTEROLOGY, 2019, 156 (06) : S647 - S647
  • [28] DUAL AGONIST OF FARNESOID X RECEPTOR AND G PROTEIN-COUPLED RECEPTOR TGR5 INHIBITS HEPATITIS B VIRUS INFECTION
    Ito, Kiyoaki
    Okumura, Akinori
    Takeuchi, Junko S.
    Watashi, Koichi
    Sakamoto, Kazumasa
    Wakita, Takaji
    Yoneda, Masashi
    HEPATOLOGY, 2019, 70 : 432A - 433A
  • [29] THE BILE ACID RECEPTOR TGR5 IN ALCOHOLIC LIVER DISEASE
    Pokhrel, Sabita
    Dilts, Matthew
    Stahl, Zachary
    Boehme, Shannon
    Chiang, John Y.
    Ferrell, Jessica M.
    HEPATOLOGY, 2022, 76 : S946 - S946
  • [30] Clinical relevance of the bile acid receptor TGR5 in metabolism
    van Nierop, F. Samuel
    Scheltema, Matthijs J.
    Eggink, Hannah M.
    Pols, Thijs W.
    Sonne, David P.
    Knop, Filip K.
    Soeters, Maarten R.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (03): : 224 - 233